{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:47:07Z","timestamp":1788817627891,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T00:00:00Z","timestamp":1390348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/npp.2014.12","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T05:50:46Z","timestamp":1390369846000},"page":"1654-1663","source":"Crossref","is-referenced-by-count":128,"title":["Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing"],"prefix":"10.1038","volume":"39","author":[{"given":"Matthew G","family":"Kirkpatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Royce","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret C","family":"Wardle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suma","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,22]]},"reference":[{"key":"BFnpp201412_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/jat\/33.8.439","volume":"33","author":"TT Abraham","year":"2009","unstructured":"Abraham TT, Barnes AJ, Lowe RH, Kolbrich Spargo EA, Milman G, Pirnay SO et al (2009). Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans. J Anal Toxicol 33: 439\u2013446.","journal-title":"J Anal Toxicol"},{"key":"BFnpp201412_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/scan\/nsq085","volume":"6","author":"J Bartz","year":"2011","unstructured":"Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A et al (2011a). Oxytocin can hinder trust and cooperation in borderline personality disorder. Soc Cogn Affect Neurosci 6: 556\u2013563.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"BFnpp201412_CR3","first-page":"301","volume":"15","author":"JA Bartz","year":"2011","unstructured":"Bartz JA, Zaki J, Bolger N, Ochsner KN (2011b). Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci 15: 301\u2013309.","journal-title":"Trends Cogn Sci"},{"key":"BFnpp201412_CR4","doi-asserted-by":"crossref","unstructured":"Bedi G, Hyman D, de Wit H (2010). Is ecstasy an \u2018empathogen\u2019? Effects of +\/-3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry 1134\u20131140.","DOI":"10.1016\/j.biopsych.2010.08.003"},{"key":"BFnpp201412_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00213-009-1635-z","volume":"207","author":"G Bedi","year":"2009","unstructured":"Bedi G, Phan KL, Angstadt M, de Wit H (2009). Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl) 207: 73\u201383.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201412_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nn0602-849","volume":"5","author":"J Born","year":"2002","unstructured":"Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002). Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5: 514\u2013516.","journal-title":"Nat Neurosci"},{"key":"BFnpp201412_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.yfrne.2011.01.002","volume":"33","author":"PA Bos","year":"2011","unstructured":"Bos PA, Panksepp J, Bluthe RM, Honk JV (2011). Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: a review of single administration studies. Front Neuroendocrinol 33: 17\u201335.","journal-title":"Front Neuroendocrinol"},{"key":"BFnpp201412_CR8","volume-title":"Ecstasy: The Complete Guide. A Comprehensive Look at the Risks and Benefits of MDMA","author":"GL Bravo","year":"2001","unstructured":"Bravo GL (2001). What does MDMA feel like? In: Holland J, (ed). Ecstasy: The Complete Guide. A Comprehensive Look at the Risks and Benefits of MDMA. Park Street Press: Rochester, US."},{"key":"BFnpp201412_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-012-2794-x","volume":"224","author":"JP Burkett","year":"2012","unstructured":"Burkett JP, Young LJ (2012). The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology (Berl) 224: 1\u201326.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201412_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.yhbeh.2010.01.006","volume":"57","author":"CH Declerck","year":"2010","unstructured":"Declerck CH, Boone C, Kiyonari T (2010). Oxytocin and cooperation under conditions of uncertainty: the modulating role of incentives and social information. Horm Behav 57: 368\u2013374.","journal-title":"Horm Behav"},{"key":"BFnpp201412_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1177\/0269881111400642","volume":"26","author":"DC de Oliveira","year":"2012","unstructured":"de Oliveira DC, Zuardi AW, Graeff FG, Queiroz RH, Crippa JA (2012). Anxiolytic-like effect of oxytocin in the simulated public speaking test. J Psychopharmacol 26: 497\u2013504.","journal-title":"J Psychopharmacol"},{"key":"BFnpp201412_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/0269881108095705","volume":"23","author":"M Di Simplicio","year":"2009","unstructured":"Di Simplicio M, Massey-Chase R, Cowen PJ, Harmer CJ (2009). Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J Psychopharmacol 23: 241\u2013248.","journal-title":"J Psychopharmacol"},{"key":"BFnpp201412_CR13","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.biopsych.2008.10.011","volume":"65","author":"B Ditzen","year":"2009","unstructured":"Ditzen B, Schaer M, Gabriel B, Bodenmann G, Ehlert U, Heinrichs M (2009). Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol Psychiatry 65: 728\u2013731.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201412_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.biopsych.2007.03.025","volume":"62","author":"G Domes","year":"2007","unstructured":"Domes G, Heinrichs M, Glascher J, Buchel C, Braus DF, Herpertz SC (2007a). Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 62: 1187\u20131190.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201412_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.biopsych.2006.07.015","volume":"61","author":"G Domes","year":"2007","unstructured":"Domes G, Heinrichs M, Michel A, Berger C, Herpertz SC (2007a). Oxytocin improves \"mind-reading\" in humans. Biol Psychiatry 61: 731\u2013733.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201412_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.psyneuen.2009.06.016","volume":"35","author":"G Domes","year":"2010","unstructured":"Domes G, Lischke A, Berger C, Grossmann A, Hauenstein K, Heinrichs M et al (2010). Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 35: 83\u201393.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp201412_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF02245245","volume":"118","author":"P Doty","year":"1995","unstructured":"Doty P, de Wit H (1995). Effect of setting on the reinforcing and subjective effects of ethanol in social drinkers. Psychopharmacology (Berl) 118: 19\u201327.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201412_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/17470910802649470","volume":"4","author":"GJ Dumont","year":"2009","unstructured":"Dumont GJ, Sweep FC, van der Steen R, Hermsen R, Donders AR, Touw DJ et al (2009). Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci 4: 359\u2013366.","journal-title":"Soc Neurosci"},{"key":"BFnpp201412_CR19","volume-title":"Pictures of Facial Affect","author":"P Ekman","year":"1976","unstructured":"Ekman P, Friesen WV (1976) Pictures of Facial Affect. Consulting Psychologists Press: Palo Alto, California."},{"key":"BFnpp201412_CR20","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/j.1360-0443.1991.tb01749.x","volume":"86","author":"MW Fischman","year":"1991","unstructured":"Fischman MW, Foltin RW (1991). Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86: 1563\u20131570.","journal-title":"Br J Addict"},{"key":"BFnpp201412_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1152\/physrev.2001.81.2.629","volume":"81","author":"G Gimpl","year":"2001","unstructured":"Gimpl G, Fahrenholz F (2001). The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81: 629\u2013683.","journal-title":"Physiol Rev"},{"key":"BFnpp201412_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2210-6-6","volume":"6","author":"DD Han","year":"2006","unstructured":"Han DD, Gu HH (2006). Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6: 6.","journal-title":"BMC Pharmacol"},{"key":"BFnpp201412_CR23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s00213-002-1131-1","volume":"162","author":"DS Harris","year":"2002","unstructured":"Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT (2002). Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 162: 396\u2013405.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201412_CR24","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0006-3223(03)00465-7","volume":"54","author":"M Heinrichs","year":"2003","unstructured":"Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54: 1389\u20131398.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201412_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0091-3057(88)90338-3","volume":"31","author":"ST Higgins","year":"1988","unstructured":"Higgins ST, Stitzer ML (1988). Time allocation in a concurrent schedule of social interaction and monetary reinforcement: effects of d-amphetamine. Pharmacol Biochem Behav 31: 227\u2013231.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201412_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00213-012-2645-9","volume":"222","author":"CM Hysek","year":"2012","unstructured":"Hysek CM, Domes G, Liechti ME (2012). MDMA enhances \u2018mind reading\u2019 of positive emotions and impairs \u2018mind reading\u2019 of negative emotions. Psychopharmacology (Berl) 222: 293\u2013302.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201412_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00213-012-2761-6","volume":"224","author":"CM Hysek","year":"2012","unstructured":"Hysek CM, Liechti ME (2012). Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex. Psychopharmacology (Berl) 224: 363\u2013376.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201412_CR28","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1046\/j.1360-0443.2003.00426.x","volume":"98","author":"BT Jones","year":"2003","unstructured":"Jones BT, Jones BC, Thomas AP, Piper J (2003). Alcohol consumption increases attractiveness ratings of opposite-sex faces: a possible third route to risky sex. Addiction 98: 1069\u20131075.","journal-title":"Addiction"},{"key":"BFnpp201412_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0091-3057(00)00218-5","volume":"66","author":"AJ Justice","year":"2000","unstructured":"Justice AJ, De Wit H (2000). Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav 66: 509\u2013515.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201412_CR30","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1007\/s11524-006-9057-2","volume":"83","author":"BC Kelly","year":"2006","unstructured":"Kelly BC, Parsons JT, Wells BE (2006). Prevalence and predictors of club drug use among club-going young adults in New York city. J Urban Health 83: 884\u2013895.","journal-title":"J Urban Health"},{"key":"BFnpp201412_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00213-013-3147-0","volume":"230","author":"MG Kirkpatrick","year":"2013","unstructured":"Kirkpatrick MG, de Wit H (2013). In the company of others: social factors alter acute alcohol effects. Psychopharmacology (Berl) 230: 215\u2013226.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201412_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1360-0443.2011.03706.x","volume":"107","author":"MG Kirkpatrick","year":"2012","unstructured":"Kirkpatrick MG, Gunderson EW, Johanson CE, Levin FR, Foltin RW, Hart CL (2012). Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction 107: 783\u2013791.","journal-title":"Addiction"},{"key":"BFnpp201412_CR33","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nature03701","volume":"435","author":"M Kosfeld","year":"2005","unstructured":"Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E (2005). Oxytocin increases trust in humans. Nature 435: 673\u2013676.","journal-title":"Nature"},{"key":"BFnpp201412_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.yhbeh.2006.06.028","volume":"50","author":"MM Lim","year":"2006","unstructured":"Lim MM, Young LJ (2006). Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Horm Behav 50: 506\u2013517.","journal-title":"Horm Behav"},{"key":"BFnpp201412_CR35","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.psyneuen.2011.02.015","volume":"36","author":"E MacDonald","year":"2011","unstructured":"MacDonald E, Dadds MR, Brennan JL, Williams K, Levy F, Cauchi AJ (2011). A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology 36: 1114\u20131126.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp201412_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnins.2013.00035","volume":"7","author":"K Macdonald","year":"2013","unstructured":"Macdonald K, Feifel D (2013). Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders. Front Neurosci 7: 35.","journal-title":"Front Neurosci"},{"key":"BFnpp201412_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10673220903523615","volume":"18","author":"K Macdonald","year":"2010","unstructured":"Macdonald K, Macdonald TM (2010). The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv Rev Psychiatry 18: 1\u201321.","journal-title":"Harv Rev Psychiatry"},{"key":"BFnpp201412_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00213-010-1780-4","volume":"209","author":"AA Marsh","year":"2010","unstructured":"Marsh AA, Yu HH, Pine DS, Blair RJ (2010). Oxytocin improves specific recognition of positive facial expressions. Psychopharmacology (Berl) 209: 225\u2013232.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201412_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.yhbeh.2011.12.001","volume":"61","author":"IS McGregor","year":"2012","unstructured":"McGregor IS, Bowen MT (2012). Breaking the loop: oxytocin as a potential treatment for drug addiction. Horm Behav 61: 331\u2013339.","journal-title":"Horm Behav"},{"key":"BFnpp201412_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0269881112456611","volume":"27","author":"MC Mithoefer","year":"2013","unstructured":"Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B et al (2013). Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol 27: 28\u201339.","journal-title":"J Psychopharmacol"},{"key":"BFnpp201412_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.biopsycho.2010.11.006","volume":"86","author":"GJ Norman","year":"2011","unstructured":"Norman GJ, Cacioppo JT, Morris JS, Malarkey WB, Berntson GG, Devries AC (2011). Oxytocin increases autonomic cardiac control: moderation by loneliness. Biol Psychol 86: 174\u2013180.","journal-title":"Biol Psychol"},{"key":"BFnpp201412_CR42","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nature12330","volume":"500","author":"SF Owen","year":"2013","unstructured":"Owen SF, Tuncdemir SN, Bader PL, Tirko NN, Fishell G, Tsien RW (2013). Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons. Nature 500: 458\u2013462.","journal-title":"Nature"},{"key":"BFnpp201412_CR43","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/npp.2013.125","volume":"38","author":"L Ramos","year":"2013","unstructured":"Ramos L, Hicks C, Kevin R, Caminer A, Narlawar R, Kassiou M et al (2013). Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Neuropsychopharmacology 38: 2249\u20132259.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201412_CR44","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0269881105058777","volume":"20","author":"J Rodgers","year":"2006","unstructured":"Rodgers J, Buchanan T, Pearson C, Parrott AC, Ling J, Hefferman TM et al (2006). Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study. J Psychopharmacol 20: 437\u2013446.","journal-title":"J Psychopharmacol"},{"key":"BFnpp201412_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"RB Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI et al (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39: 32\u201341.","journal-title":"Synapse"},{"key":"BFnpp201412_CR46","doi-asserted-by":"crossref","unstructured":"Shahrestani S, Kemp AH, Guastella AJ (2013). The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: a meta-analysis. Neuropsychopharmacology.","DOI":"10.1038\/npp.2013.86"},{"key":"BFnpp201412_CR47","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1210\/en.2009-1271","volume":"151","author":"DK Shahrokh","year":"2010","unstructured":"Shahrokh DK, Zhang TY, Diorio J, Gratton A, Meaney MJ (2010). Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. Endocrinology 151: 2276\u20132286.","journal-title":"Endocrinology"},{"key":"BFnpp201412_CR48","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.biopsych.2009.06.009","volume":"66","author":"SG Shamay-Tsoory","year":"2009","unstructured":"Shamay-Tsoory SG, Fischer M, Dvash J, Harari H, Perach-Bloom N, Levkovitz Y (2009). Intranasal administration of oxytocin increases envy and schadenfreude (gloating). Biol Psychiatry 66: 864\u2013870.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201412_CR49","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1177\/0269881106060764","volume":"20","author":"HR Sumnall","year":"2006","unstructured":"Sumnall HR, Cole JC, Jerome L (2006). The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. J Psychopharmacol 20: 670\u2013682.","journal-title":"J Psychopharmacol"},{"key":"BFnpp201412_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-0101-1","volume-title":"Manual of Pharmacologic Calculations","author":"RJ Tallarida","year":"1981","unstructured":"Tallarida RJ, Murray RB (1981) Manual of Pharmacologic Calculations. Springer: Heidelberg, Germany."},{"key":"BFnpp201412_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0376-8716(03)00172-8","volume":"72","author":"M Tancer","year":"2003","unstructured":"Tancer M, Johanson CE (2003). Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. Drug Alcohol Depend 72: 33\u201344.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201412_CR52","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.neuroscience.2007.02.032","volume":"146","author":"MR Thompson","year":"2007","unstructured":"Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS (2007). A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (\u2018ecstasy\u2019). Neuroscience 146: 509\u2013514.","journal-title":"Neuroscience"},{"key":"BFnpp201412_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fnins.2012.00174","volume":"6","author":"MH van Ijzendoorn","year":"2012","unstructured":"van Ijzendoorn MH, Bhandari R, van der Veen R, Grewen KM, Bakermans-Kranenburg MJ (2012). Elevated salivary levels of oxytocin persist more than 7\u2009h after intranasal administration. Front Neurosci 6: 174.","journal-title":"Front Neurosci"},{"key":"BFnpp201412_CR54","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","volume":"189","author":"CD Verrico","year":"2007","unstructured":"Verrico CD, Miller GM, Madras BK (2007). MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology (Berl) 189: 489\u2013503.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201412_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0006-8993(93)90155-G","volume":"620","author":"PA Vincent","year":"1993","unstructured":"Vincent PA, Etgen AM (1993). Steroid priming promotes oxytocin-induced norepinephrine release in the ventromedial hypothalamus of female rats. Brain Res 620: 189\u2013194.","journal-title":"Brain Res"},{"key":"BFnpp201412_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00213-011-2498-7","volume":"220","author":"MC Wardle","year":"2012","unstructured":"Wardle MC, de Wit H (2012). Effects of amphetamine on reactivity to emotional stimuli. Psychopharmacology (Berl) 220: 143\u2013153.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201412_CR57","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0091-3057(02)00818-3","volume":"73","author":"TL White","year":"2002","unstructured":"White TL, Justice AJ, de Wit H (2002). Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73: 729\u2013741.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201412_CR58","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1523\/JNEUROSCI.5593-08.2009","volume":"29","author":"M Yoshida","year":"2009","unstructured":"Yoshida M, Takayanagi Y, Inoue K, Kimura T, Young LJ, Onaka T et al (2009). Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci 29: 2259\u20132271.","journal-title":"J Neurosci"},{"key":"BFnpp201412_CR59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0010-0277(97)00003-6","volume":"63","author":"AW Young","year":"1997","unstructured":"Young AW, Rowland D, Calder AJ, Etcoff NL, Seth A, Perrett DI (1997). Facial expression megamix: tests of dimensional and category accounts of emotional recognition. Cognition 63: 271\u2013313.","journal-title":"Cognition"},{"key":"BFnpp201412_CR60","doi-asserted-by":"publisher","first-page":"e1128","DOI":"10.1371\/journal.pone.0001128","volume":"2","author":"PJ Zak","year":"2007","unstructured":"Zak PJ, Stanton AA, Ahmadi S (2007). Oxytocin increases generosity in humans. PLoS ONE 2: e1128.","journal-title":"PLoS ONE"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201412","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:48:02Z","timestamp":1684439282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,22]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["BFnpp201412"],"URL":"https:\/\/doi.org\/10.1038\/npp.2014.12","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,22]]}}}